The clinical parameters PSA, PSAD, PSAV, and maxPI-RADS showed moderate AUC values (0.681–0.747, p < 0.05) for indicating PCa risk reclassification (Figure 3 and Table 3). This evidence concerns the gene KLK3 and posterior cortical atrophy.